Watchlist Price Alert

ArriVent BioPharma Inc. C... (AVBP)

NASDAQ: AVBP · Real-Time Price · USD

19.57

-0.58 (-2.88%)

At close: May 12, 2025, 11:26 AM

ArriVent BioPharma Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q1 2022
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Mar 31, 2022
Cash & Equivalents	74.29M	150.39M	298.67M	317.39M	150.39M	141.36M	157.83M	-163.37M	163.37M	n/a
Short-Term Investments	144.57M	n/a	n/a	n/a	n/a	25M	25M	326.74M	n/a	n/a
Long-Term Investments	47.68M	n/a	n/a	n/a	n/a	106K	n/a	n/a	n/a	n/a
Other Long-Term Assets	126K	2.84M	125K	108K	2.84M	1.96M	82K	-163.37M	72K	-37.28M
Receivables	500K	761K	750K	875K	761K	1.09M	258K	n/a	500K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	226.98M	159.97M	308.51M	327.48M	159.97M	179.98M	198.69M	163.37M	182.62M	37.28M
Property-Plant & Equipment	154K	291K	219K	250K	291K	44K	76K	n/a	139K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	47.96M	3.13M	344K	358K	3.13M	2.11M	158K	-163.37M	211K	-37.28M
Total Assets	274.94M	163.1M	308.86M	327.84M	163.1M	182.09M	198.84M	n/a	182.83M	n/a
Account Payables	3.78M	4.53M	3.81M	4.1M	4.53M	4.82M	6.46M	n/a	3.09M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	4.16M	3.35M	n/a	n/a	n/a	n/a	n/a	n/a	2.46M	n/a
Total Current Liabilities	17.27M	11.62M	12.1M	9.98M	11.62M	10.1M	12.81M	n/a	8.36M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	304.49M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-41.22M
Total Long-Term Liabilities	14K	304.67M	98K	138K	177K	304.49M	n/a	n/a	11K	-41.22M
Total Liabilities	17.29M	316.29M	12.2M	10.12M	11.8M	10.1M	12.81M	n/a	8.37M	-41.22M
Total Debt	176K	317K	250K	285K	317K	44K	76K	n/a	139K	n/a
Common Stock	3K	n/a	3K	3K	n/a	4K	4K	n/a	4K	n/a
Retained Earnings	-238.33M	-157.84M	-197.14M	-175.26M	-157.84M	-136.65M	-122.25M	n/a	-88.51M	n/a
Comprehensive Income	-211K	n/a	0.00	n/a	n/a	-4K	-4K	-85.11M	-4K	-48.64M
Shareholders Equity	257.65M	-153.19M	296.66M	317.72M	151.3M	171.99M	186.03M	174.46M	174.46M	41.22M
Total Investments	192.25M	n/a	n/a	n/a	n/a	25.11M	25M	326.74M	n/a	n/a